# Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening

> **NCT06512311** · NA · RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 240 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DIAGNOSTIC_TEST:** CBMed Drug Screening Plattform

## Key facts

- **NCT ID:** NCT06512311
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06512311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06512311, "Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06512311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*